The trials below are instructed and monitored by Dr. Tu Shih Chun +886 910563223, Vice President of Taichung Taiwan Ren Ai Hospital – 台中仁愛醫院副院長.
Further verification and information available upon request
Th1 protein is a promising therapeutic candidate with the potential to address a range of autoimmune diseases and potentially contribute to anti-aging effects. Preliminary trials have demonstrated encouraging results within relatively short time frames. Dr. Tu Shih Chun indicated these diseases had no cure up until now. He also expressed that most patients below experienced antiaging effects via his survey.
Psoriasis Case Studies:
-
Case 1: A 30-year-old Taiwanese woman with a 10-year history of psoriasis experienced complete symptom resolution within one month of initiating Th1 protein supplementation. Photographs taken two weeks into treatment demonstrated significant improvement.
-
Case 2: A 45-year-old Taiwanese man diagnosed with psoriasis for eight years reported a significant reduction in itching and the onset of skin dryness one month after commencing Th1 protein supplementation. Treatment is ongoing.
-
Case 3: A 47-year-old Taiwanese woman with over a decade of psoriasis, including prior attempts at various treatments, experienced complete resolution of itching within one month of initiating Th1 protein supplementation. Color fading and skin peeling were observed during this period. Treatment remains ongoing. Click image to enlarge, all photos are original.
Crohn’s Disease Case Study:
A 40-year-old female in Taiwan with a 20-year history of Crohn’s Disease experienced a temporary remission of diarrhea while taking a Th1 protein supplement. Upon discontinuing the supplement, diarrhea returned. Reintroducing the Th1 protein successfully alleviated diarrhea again. After one month of consistent supplementation, the patient reported a complete resolution of Crohn’s Disease symptoms. Photos not available.
Sjogren’s Syndrome Case Study:
A 35-year-old Taiwanese female presented with a history of Sjogren’s syndrome spanning several years. Key symptoms included:
- Ocular: Dry eyes, eye irritation, and blurred vision.
- Oral: Dry mouth, oral lesions, and difficulty swallowing.
The patient reported experiencing significant side effects from previous treatment regimens.
Following the initiation of Th1 protein supplementation, a marked improvement was observed within one month. All Sjogren’s syndrome-related symptoms resolved completely, and the patient no longer required any additional treatment.
Stomach Cancer Case Study:
A 28-year-old Taiwanese male patient presented with late-stage stomach cancer and underwent partial gastrectomy. Following surgery, the patient experienced a significant improvement in his condition within three weeks of initiating Th1 protein supplementation. This improvement enabled the patient to resume his previous occupation as a food delivery driver.
The young man experienced a rapid decline in his condition, necessitating paracentesis (abdominal fluid removal) as his initial supply of Th1 protein was depleted. He is currently awaiting the arrival of a new batch of Th1 protein.
New Trial Focus:
Investigating potential therapeutic applications of Focus in FSHD, cancer, and monitoring measurable antiaging biomarkers.
Disclaimer:
These case studies are presented for informational purposes only and does not constitute medical advice. Consulting with a qualified healthcare professional is crucial for proper diagnosis and treatment of this condition.
